Skip to main content
SpringerLink
Log in

The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

The effects of OKY-046, a thromboxane A2 synthetase inhibitor, on hepatic dysfunction produced by liver cell ischemia were studied in an experimental model of rats with obstructive jaundice. The experiments were performed 7 days after the rats underwent bile duct ligation. Warm total ischemia of the liver was induced by Pringle's method over a 20-min period and the animals were divided into two groups according to whether or not OKY-046 was administered. The reperfusion time was 30 min in each group. OKY-046 was administered via the femoral vein at a rate of 100 μg/kg per min from 15 min before the blockade to the end of the experiment. The level of ATP in the liver tissue of the OKY-046 group was elevated slightly, but not significantly, compared to that of the control group. The ratio TXB2/6-keto PGF1α in the liver tissue was lower in the OKY-046 group than in the control group, and significant differences were found between the two groups in the water content of the liver and the mitochondrial score as examined by transmission electron microscopy. Thus, it was observed that an improvement in the balance of TXA2 and PGI2 associated with OKY-046 administration protected the cellular structure of the mitochondria in the rat liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pringle JH (1908) Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 48:541–549

    Google Scholar 

  2. Ujiie A, Hiraku S, Naito J (1985) Parmacological actions of OKY-046, a specific inhibitor of thromboxane synthetase, with special reference to inhibition of thromboxane A2 production and acceleration of prostacyclin production (in Japanese with English abstract). Ouyou Yakuri 29:659–685

    Google Scholar 

  3. Sugio K, Yamada K, Kawasaki T (1986) Analysis of adenine nucleotides by high-performance liquid chromatography. J Chromatogr 361:427–431

    Google Scholar 

  4. Kawano K, Sugita M, Oka M, Tabata N (1987) A simple, rapid and simultaneous extraction of thromboxane B2, 6-keto-prostaglandin F1α and prostaglandin E2 (in Japanese with English abstract). Enshou (Jpn J Inflammation) 7:511–515

    Google Scholar 

  5. Jennings RB, Ganote CE (1974) Structural changes in myocardium during acute ischemia. Circ Res 34,35 [Suppl III]:156–172

    Google Scholar 

  6. Jennings RB (1976) Discussion (relationship of acute ischemia to functional defects and irreversibility). Circulation 53 [Suppl I]:26–29

    Google Scholar 

  7. Van der Meer C, Van der Kley G, Valkenburg P (1976) Studies on the course of death after permanent and temporary occlusion of the portal vein in rats. Circ Shock 3:191–202

    Google Scholar 

  8. Hoshino S, Nonami T (1985) Systemic hemodynamics and oxygen metabolism in acute portal vein occlusion and following restoration of portal vein flow in canines (in Japanese with English abstract). Nippon Geka Gakkai Zasshi (J Jpn Surg Soc) 86:738–751

    Google Scholar 

  9. Raffucci FL (1953) The effects of temporary occlusion of the afferent hepatic ischemia. Surgery 33:342

    Google Scholar 

  10. Farkouh EF, Anna MD, Jean-Guy B, Lloyd DM (1971) Predictive value of liver biochemistry in acute hepatic ischemia. Surg Gynecol Obstet 32:832

    Google Scholar 

  11. Marubayashi S, Dohi K, Ezaki H, Hayashi K, Kawasaki T (1982) Preservation of ischemic liver failure in the rat liver mitochondrial functions and liver viability with CoQ10. Surgery 91:631–637

    Google Scholar 

  12. Marubayashi S, Takenaka M, Dohi K, Ezaki H, Kawasaki T (1980) Adenine nucleotide metabolism during hepatic ischemia and subsequent blood reflow periods and its relation to organ viability. Transplantation 30:294–296

    Google Scholar 

  13. Elman R, Cole WH (1934) Hemorrhage and shock as causes of death following acute portal obstruction. Arch Surg 28:1165–1175

    Google Scholar 

  14. Miura M (1974) The influence of permanent portal vein occlusion on dogs with portapulmonary shunt by splenopneumopexy (in Japanese with English abstract). Kagoshima Daigaku Igaku Kaishi 25:353–375

    Google Scholar 

  15. Olcay I, Kitahama A, Miller RH, Drapanas T, Trejo RA, Luzio NRD (1974) Reticuloendothelial dysfunction and endotoxemia following portal vein occlusion. Surgery 75:64–70

    Google Scholar 

  16. Sugiura K, Yamamoto Y, Kobai H, Watanabe C, Otsuka T (1986) Effects of thromboxane synthetase inhibitor on hepatic circulation in canine endotoxin shock (in Japanese with English abstract). Kinkyu Igaku 10:455–459

    Google Scholar 

  17. Bergan J, Teixeira E, Yu H, Clarke W, Coburn M (1968) Hyperkalemia accompanying canine portal venous occlusion. Surgery 64:629–633

    Google Scholar 

  18. Hinshaw LB, Emerson TE, Iampietro PF, Brake CM (1962) A comparative study of the hemodynamic action of histamine and endotoxin. Am J Physiol 203:600–606

    Google Scholar 

  19. Nies AS, Forsyth RP, Williams HE, Melmon KL (1968) Contribution of kinins to endotoxin shock in unanesthetized rhesus monkeys. Circ Res 22:155–164

    Google Scholar 

  20. Lambotte L, de Hemptinne B, Alvarez-Lopez A, Besse T (1988) Effects of calcium blocking agents and prostaglandin I2 or E2 on the tolerance of the rat liver to ischemia. Transplant Proc 10:986

    Google Scholar 

  21. Araki H, Lefer AM (1980) Cytoprotective actions of prostacyclin during hypoxia in the isolated perfused cat liver. Am J Physiol 238:176–181

    Google Scholar 

  22. Noshima S (1992) Effect of prostacycline analogue OP-41483 and perfusate on liver preservation by simple hypothermia in rats. Surg Today 22:149–154

    Google Scholar 

  23. Sikujara O, Monden M, Toyoshima K, Okamura J, Kosaki G (1983) Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury. Transplantation 36:238–243

    Google Scholar 

  24. Kobayashi T (1993) Therapeutic effects of thromboxane A2 inhibitor for complete hepatic ischemia in rats (in Japanese with English abstract). Yamaguchi Igaku 42:69–76

    Google Scholar 

  25. Besse T, Gustin T, Claeys N, Schroeyers P, Lambotte L (1989) Effect of PGI2 and thromboxane antagonist on liver ischemic injury. Eur Surg Res 21:213–217

    Google Scholar 

  26. Isozaki H, Okajima K, Hara H, Kobayashi M (1994) The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury. Surg Today 24:435–440

    Google Scholar 

  27. Kuroe K, Kurokawa T, Nishikimi M, Nonami A, Harada A, Nakao A, Takagi H (1991) Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats. Eur Surg Res 23:20–26

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Surgery, Yamaguchi University School of Medicine, 1144 Kogushi, 755, Ube, Japan

    Tsuyoshi Takahashi

Authors
  1. Tsuyoshi Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takahashi, T. The effects of thromboxane A2 synthetase inhibitor (OKY-046) on complete hepatic ischemia in rats with obstructive jaundice. Surg Today 26, 15–20 (1996). https://doi.org/10.1007/BF00311986

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00311986

Key Words

Search

Navigation